Vincent Medical's (HKG:1612) profit attributable to owners rose to HK$104.4 million for 2025, from HK$69.2 million a year earlier, according to a Wednesday Hong Kong bourse filing.
Basic earnings per share came in at HK$0.1618, compared with HK$0.1075 a year earlier.
Revenue increased 17% to HK$932.8 million from HK$801.0 million in 2024.
The board declared a final dividend of HK$0.026 per share, bringing total dividends for the year to HK$0.05 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.